/PRNewswire/ Milestone Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative.
/PRNewswire/ Milestone Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative.
Milestone Pharmaceuticals Announces Appointment of David Bharucha, M.D., Ph.D., as Chief Medical Officer - read this article along with other careers information, tips and advice on BioSpace
Today, the Multiple Myeloma Research Foundation (MMRF) announced that new insights related to novel targets, risk assessment, and precision medicine approaches generated through the use of the MMRF landmark CoMMpass Study will be presented at the 63rd American Society of Hematology (ASH) Annual Meeting and Exposition. In total, ASH will feature 33 presentations developed through the work of more than 200 researchers from 180 institutions all using the CoMMpass data. - Click here if this is your press release! - eTurboNews | Trends | Travel News